INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV
Position in AZN — Astrazeneca PLC
CIK 867926
ATLANTA, GA
Position in AZN
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$1,415,892
-$56,749 QoQ
Shares Held
7,467
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#586
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV holds $25,648,176 across 11 Drug Manufacturers - General names. AZN ranks #7 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,818 | $8,177,714 | |
| 2 | ABBV |
AbbVie Inc.
|
18,592 | $4,678,490 | |
| 3 | JNJ |
Johnson & Johnson
|
10,140 | $2,575,255 | |
| 4 | MRK |
Merck & Co., Inc.
|
19,079 | $2,451,651 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
18,616 | $2,351,945 | |
| 6 | PFE |
Pfizer Inc
|
93,803 | $2,258,776 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
7,467 | $1,415,892 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
17,235 | $993,080 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,415,892 | 7,467 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $1,472,641 | 7,467 | Shares | Sole | 2026-04-27 | |
| No filing history on record for this holder in this stock. | ||||||